SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.830-3.7%1:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: donpat who wrote (3353)12/12/2014 10:46:40 AM
From: drkaz  Read Replies (1) of 12871
 
This is the earliest references that I have access to: Dates from Nature articles in 2011:

nature.com

Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
  • Claire Marie Filone &
  • Lisa Hensley

  • Were the USAMRIID people involved in this one

    nature.com

    Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
  • Andrew S. Herbert,
  • Ana I. Kuehne,
  • Gordon Ruthel &
  • John M. Dye


  • Were the USAMRIID people involved in this one

    Both are a bit jargony and technical - but as papers in the journal 'Nature' - they are actually fairly easy to read. There are some less technical summaries available online as well if you want somebody to help you cut through the jargon.

    Here are a couple that are not too bad:
    the-scientist.com

    einstein.yu.edu

    Report TOU ViolationShare This Post
     Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext